Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers.
Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers.
复制标题
DOI：
10.1186/1478-4505-13-9
复制
发表时间：
2015-02-02
影响因子：
4
通讯作者：
Kieny MP
中科院分区：
文献类型：
--
作者：
Adam T;Røttingen JA;Kieny MP
2013年5月，世卫组织成员国要求世卫组织建立全球卫生研究与发展（R&D）观察站，作为战略工作计划的一部分，以促进创新、建设能力、改善获取机会和调动资源，以应对对世界最贫困国家造成严重影响的疾病。建立全球卫生研发观察站的理由是提供一个监测和分析卫生研发资源流、产品管道和研究成果的机制，旨在帮助查明差距，为新研发投资的优先事项设定提供信息，这些投资将通过新的全球卫生研发融资和协调机制来实施，并由所有利益攸关方利用，为国家、民间社会和私营部门的卫生研究政策决策提供信息。作为实现全球卫生研发目标的机制之一，世界卫生组织正在发起征集论文，以卫生研究政策和系统专题系列的形式发表，以贡献最先进的知识和创新方法来分析、解释和报告卫生研发信息。此外，作为为未来世卫组织召集的协调机制提供信息的关键资源，该机制将用于为新的研发投资制定循证优先事项，并通过拟议的新的卫生研发全球融资和协调机制来资助。本文的在线版本 (doi:10.1186/1478-4505-13-9) 包含补充材料，可供授权用户使用。
In May 2013, the WHO Member States requested the WHO to establish a Global Observatory on Health Research and Development (R&D), as part of a strategic work-plan to promote innovation, build capacity, improve access, and mobilize resources to address diseases that disproportionately affect the world’s poorest countries. The rationale for establishing a Global Observatory on Health R&D is to provide a mechanism to monitor and analyse health R&D resource flows, product pipelines, and research outputs, aiming to contribute to the identification of gaps to inform priority-setting for new R&D investments to be operationalized through a new global financing and coordination mechanism for health R&D and utilized by all stakeholders informing health research policy decisions in countries, civil society, and the private sector. As one of the mechanisms to achieve the goals of the Global Observatory on Health R&D, the WHO is launching a Call for Papers to be published as a Thematic Series in Health Research Policy and Systems to contribute state-of-the-art knowledge and innovative approaches to analyse, interpret, and report on health R&D information. Further, to serve as a key resource to inform the future WHO-convened coordination mechanism, which will be utilized to generate evidence-informed priorities for new R&D investments to be financed through a proposed new global financing and coordination mechanism for health R&D. The online version of this article (doi:10.1186/1478-4505-13-9) contains supplementary material, which is available to authorized users.
影响因子：
168.9
作者：
Rottingen, John-Arne;Regmi, Sadie;Terry, Robert F.
通讯作者：
Terry, Robert F.